tiprankstipranks
Trending News
More News >
C21 Investments Inc (CXXIF)
OTHER OTC:CXXIF

C21 Investments (CXXIF) AI Stock Analysis

Compare
43 Followers

Top Page

C21 Investments (CXXIF) vs. SPDR S&P 500 ETF (SPY)

C21 Investments Business Overview & Revenue Model

Company DescriptionC21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. It offers packaged and wholesale flower, vaporizer pens, cured extracts, edibles, pre-rolls, tinctures, and topicals; and payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.
How the Company Makes Money

C21 Investments Financial Statement Overview

Summary
C21 Investments is experiencing challenges in revenue generation and profitability, as indicated by declining revenue and negative net profit margins. The balance sheet reflects moderate leverage but a decline in stockholders' equity. Cash flow sustainability is a concern due to a significant decline in free cash flow and negative net income.
Income Statement
45
Neutral
C21 Investments shows declining revenue with a negative net profit margin, indicating profitability challenges. The TTM data reflects a challenging year with negative net income. Gross and EBIT margins show some efficiency, but the declining revenue trend from earlier years is concerning.
Balance Sheet
55
Neutral
The balance sheet of C21 Investments indicates a moderate debt-to-equity ratio, reflecting manageable leverage. While there is a decline in stockholders' equity, the equity ratio remains relatively stable. However, the company has faced challenges in maintaining positive net income, affecting return on equity.
Cash Flow
50
Neutral
Cash flow analysis shows a significant decline in free cash flow in the TTM compared to the previous year, reflecting operational challenges. The operating cash flow to net income ratio is not favorable due to negative net income, indicating potential cash flow management issues.
Breakdown
TTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
28.56M28.29M28.89M32.98M36.13M37.71M
Gross Profit
11.78M11.15M13.40M18.81M18.65M13.32M
EBIT
930.99K1.47M3.96M9.75M7.52M-1.18M
EBITDA
2.96M3.34M6.26M11.68M12.56M2.22M
Net Income Common Stockholders
-4.43M-3.31M293.21K9.95M-6.11M-32.56M
Balance SheetCash, Cash Equivalents and Short-Term Investments
539.65K2.41M1.89M3.07M6.24M3.08M
Total Assets
1.66M54.53M58.31M61.85M68.81M61.45M
Total Debt
0.0010.72M12.14M18.67M27.30M36.07M
Net Debt
-539.65K8.31M10.24M15.60M21.06M32.99M
Total Liabilities
224.80K23.48M24.00M26.87M43.47M47.87M
Stockholders Equity
1.44M31.05M34.32M34.98M25.34M13.58M
Cash FlowFree Cash Flow
-2.58M5.46M5.46M4.27M9.70M5.00M
Operating Cash Flow
1.23M5.90M5.90M6.84M9.92M5.51M
Investing Cash Flow
-3.44M-390.93K-390.93K-1.39M-1.10M-4.54M
Financing Cash Flow
1.94M-6.68M-6.68M-7.84M-5.70M-7.10M

C21 Investments Risk Analysis

C21 Investments disclosed 50 risk factors in its most recent earnings report. C21 Investments reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

C21 Investments Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$17.55M-13.58%
54
Neutral
$5.31B3.28-45.10%2.80%16.76%0.02%
$17.64M18.836.18%
$20.79M-2.68%
$23.53M-24.12%
$22.89M-203.40%
44
Neutral
C$26.31M-31.24%44.21%21.93%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CXXIF
C21 Investments
0.16
-0.11
-40.74%
MILFF
1CM Inc
0.19
-0.28
-59.57%
ROMJF
Rubicon Organics
0.32
-0.05
-13.51%
VEXTF
Vext Science
0.09
-0.09
-50.00%
AVCNF
Avicanna
0.17
0.00
0.00%
TSE:GWAY
Greenway Greenhouse Cannabis Corp.
0.20
-0.06
-23.08%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.